The new WHO 2022 category of molecularly defined renal carcinomas: Accessible to practicing pathologists-Reference-Cited by-同舟云学术

The new WHO 2022 category of molecularly defined renal carcinomas: Accessible to practicing pathologists

Published:2023-08-17 Issue:6 Volume:160 Page:545-548
ISSN:0002-9173
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:

Author:

Smith Steven Christopher¹^ORCID,Wobker Sara E²^ORCID

Affiliation:

1. Departments of Pathology, Surgery, and Massey Comprehensive Cancer Center, VCU School of Medicine, and Richmond Veterans Affairs Medical Center , Richmond, VA , US

2. Department of Pathology and Laboratory Medicine, University of North Carolina , Chapel Hill, NC , US

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

https://academic.oup.com/ajcp/article-pdf/160/6/545/53932561/aqad101.pdf

Reference14 articles.

1. History of the development of the classification of renal cell neoplasia;Delahunt,2005

2. Tumours of the urinary system and male genital organs, WHO classification of tumours;Eble,2004

3. Lessons from 801 clinical TFE3/TFEB fluorescence in situ hybridization assays performed on renal cell carcinoma suspicious for MiTF;Wang

4. What’s new in WHO fifth edition—urinary tract;Comperat,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The New WHO Category of “Molecularly Defined Renal Carcinomas”: Clinical and Diagnostic Features and Management Implications;Urologic Oncology: Seminars and Original Investigations;2024-07

2. MED15::TFE3 fusion renal cell carcinoma with extensive cystic change: A clinicopathologic and molecular genetic study of 2 cases, with an emphasis on differential diagnosis;American Journal of Clinical Pathology;2024-02-22